Medicaid Drug Rebates and Pharma's Future

Medicaid's impact on the pharma industry is growing. Based on early reports, Medicaid enrollments dominate public exchange sign-ups. Medicaid will be setting the pace for pharmacy reimbursements, per Obamacare Will Squeeze Pharmacy Profits. And, manufacturers will need to wrestle with new guidance on bona fide service fees when the Average Manufacturer Price (AMP) Final Rule is released in January.

Want to learn more? Join me in February, when I'll discuss "How Medicaid Will Shape Pharma’s Future" as the keynote speaker at the 2014 Medicaid Rebate Summit, in Washington, DC. See more below. Check out the Medicaid Rebate Summit blog for regular updates.

Other speakers on this top-notch agenda come from such companies as Amneal Pharmaceuticals, Apexus/340B Prime Vendor Program, Biotechnology Industry Organization (BIO), CMS, Daiichi Sankyo, Dendreon, DHHS, CMS, Eli Lilly, Genentech, Hospira, HP Enterprise Services, HRSA, Iroko Pharmaceuticals, Janssen Pharmaceuticals, Johnson & Johnson, Mylan Pharmaceuticals, NACDS, NCPDP, OIG, Pfizer, Pharmacy Services Manager, Oregon MMIS, Purdue Pharma, Vertex Pharmaceuticals, and more.

Drug Channels readers can register with code DC15 and receive 15% off the standard registration rates. Thanks, Conference Forum!

OFFICIAL DESCRIPTION FROM THE CONFERENCE FORUM

Adam J. Fein, Ph.D., to Keynote 2nd Annual Medicaid Rebate Summit (Feb. 26-27, 2014)

In anticipation of the Final Rule and Medicaid expansion, Dr. Fein will set the stage for the 2nd Annual Medicaid Rebate Summit with his address “How Medicaid Will Shape Pharma's Future”. Dr. Fein was chosen as the 2014 Keynote by being the most recommended speaker by manufacturers for his insights into pharmaceutical economics and the impact on Medicaid Drug Rebates.

The MRS Summit helps pharmaceutical, biotech and generic drug manufacturers along with states and pharmacy leaders to navigate the complexities of the Medicaid Rebate process.

Co-Chairs Jim Abrams, MBA, Director, Government Pricing & Reporting, Mylan Pharmaceuticals and Stephanie Kupski agreed on the timeliness of the agenda due to “the GP community eagerly awaiting the release of the final AMP rule in January”.

Medicaid Rebate Summit Conference Details:
Date: February 26-27, 2014
Location: Park Hyatt Washington, Washington, DC

The conference has two track choices to allow individual event customization:

• Track A: Operational and Compliance Lessons for Medicare Part D & State Rebate Initiatives 


• Track B: Strategic Government Business Contracting and Analysis

Register with code DC15 for a 15% discount and be sure to take advantage of our Networking and Meeting Tool and stay up to date with our Event Blog!